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Abstract
Mutations that impair the proliferation of enteric neural crest-derived cells (ENCDC) cause 
Hirschsprung disease, a potentially lethal birth defect where the enteric nervous system (ENS) is 
absent from distal bowel. Inosine 5′ monophosphate dehydrogenase (IMPDH) activity is essential 
for de novo GMP synthesis, and chemical inhibition of IMPDH induces Hirschsprung disease-like 
pathology in mouse models by reducing ENCDC proliferation. Two IMPDH isoforms are 
ubiquitously expressed in the embryo, but only IMPDH2 is required for life. To further understand 
the role of IMPDH2 in ENS and neural crest development, we characterized a conditional Impdh2 
mutant mouse. Deletion of Impdh2 in the early neural crest using the Wnt1-Cre transgene 
produced defects in multiple neural crest derivatives including highly penetrant intestinal 
aganglionosis, agenesis of the craniofacial skeleton, and cardiac outflow tract and great vessel 
malformations. Analysis using a Rosa26 reporter mouse suggested that some or all of the 
remaining ENS in Impdh2 conditional-knockout animals was derived from cells that escaped 
Wnt1-Cre mediated DNA recombination. These data suggest that IMPDH2 mediated guanine 
nucleotide synthesis is essential for normal development of the ENS and other neural crest 
derivatives.
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Introduction
The enteric nervous system (ENS) is a network of ganglia distributed throughout the 
digestive tract that autonomously controls motility, secretion, and blood flow (Furness, 
2006). The ENS develops from migratory neural crest-derived cells that invade, migrate 
through, and colonize the nascent bowel while dividing rapidly, eventually reorganizing into 
discrete ganglia, and differentiating into glia or one of more than fifteen functional classes of 
neuron (Goldstein et al., 2013; Lake and Heuckeroth, 2013; Obermayr et al., 2013). A 
complete and functional ENS is required for life. Incomplete colonization of the bowel by 
ENS precursors results in Hirschsprung disease (HSCR), a life-threatening oligogenic birth 
defect where a segment of distal bowel is devoid of enteric neurons (aganglionosis). Bowel 
colonization critically requires that ENCDC proliferate efficiently (Lake et al., 2013; 
Simpson et al., 2007). For this reason, many of the mutations that cause HSCR impair ENS 
precursor proliferation or self-renewal (Amiel et al., 2008; Lake and Heuckeroth, 2013). 
Inhibition of ENCDC proliferation with the antimetabolite immunosuppressant 
mycophenolic acid (MPA) also causes aganglionosis in mice (Lake et al., 2013) and 
enhances the penetrance and phenotypic severity of mutations that model HSCR. MPA 
blocks the rate-limiting step of de novo guanine nucleotide synthesis by inhibiting inosine 5′ 
monophosphate dehydrogenase (IMPDH), a ubiquitous metabolic enzyme whose expression 
is relatively enriched in ENCDC (Lake et al., 2013). Prenatal MPA exposure in humans is 
also associated with a specific pattern of birth defects (Anderka et al., 2009), some of which 
are plausibly due to disruptions in neural crest development (Lin et al., 2011).
Relatively little is known about the developmental roles of IMPDH, which is present in two 
isoforms encoded by separate genes in vertebrates. IMPDH2 is widely expressed and is 
enriched in activated lymphocytes, tumor cells, fetal tissues, and other proliferative cells 
(Zimmermann et al., 1995; Senda and Natsumeda, 1994; Nagai et al., 1992). Homozygous 
Impdh2 deletion in mice results in early lethality prior to embryo implantation, while 
heterozygous deletion results in a subtle reduction in the IMPDH activity of splenic 
lymphocytes (Gu et al., 2000). IMPDH1 is also ubiquitously expressed, but does not appear 
to be regulated by proliferative demand, and has a specialized but poorly-understood role in 
the retina (Aherne et al., 2004; Bowne et al., 2006; Gunter et al., 2008; Nagai et al., 1992; 
Zimmermann et al., 1996), where missense mutations in IMPDH1 cause a form of 
autosomal dominant retinitis pigmentosa in humans. In mice, Impdh1 is dispensable for life 
and its deletion results in a relatively mild retinal phenotype (Aherne et al., 2004; Gu et al., 
2003) suggesting Impdh2 is essential for early development.
Our previous experiments with the non-selective IMPDH inhibitor mycophenolic acid did 
not target IMPDH inhibition to neural crest derivatives, nor did they indicate whether 
IMPDH1 and IMPDH2 have redundant roles or whether one isoform is uniquely required 
for neural crest development. Since Impdh1 homozygous mutant mice are viable and fertile 
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and thus must form a complete and functional ENS, we hypothesized that Impdh2 is 
required within the neural-crest lineage for ENCDCs to proliferate efficiently and colonize 
the bowel. To further explore the role for this basic metabolic pathway in development, we 
deleted Impdh2 in the early neural crest of mice using an Impdh2loxP allele and Wnt1-Cre 
transgene.
The Tg(Wnt1-cre)11Rth transgenic line (referred to as Wnt1-Cre), (Danielian et al., 1998) is 
a Cre-expressing line widely-used for tissue-specific recombination within the developing 
ENS and other neural crest derivatives. In this transgene, the Cre sequence is inserted into a 
Wnt1 minigene construct between the endogenous promoter and a 5.5 kb downstream 
enhancer (Echelard et al., 1993). These elements confer an expression pattern nearly 
identical to endogenous Wnt1 mRNA beginning in the developing midbrain and later 
extending, restricted to the closing neural folds and dorsal neural tube, cephalad into the 
telencephalon and caudad down the entire length of the neural tube (Echelard et al., 1994). 
While Wnt1 expression is not maintained during neural crest delamination, Wnt1-Cre 
efficiently recombines the ancestors of all examined neural crest derivatives including the 
peripheral nervous system, adrenal medulla, great vessels, melanocytes (Jiang et al., 2000), 
craniofacial skeleton (Jiang et al., 2002), and the enteric nervous system (Lee et al., 2004).
Here we demonstrate that Impdh2 expression is required in the neural crest for development 
of the craniofacial skeleton, cardiac outflow tract, and enteric nervous system. In the ENS, 
loss of Impdh2 results in extensive bowel aganglionosis. Furthermore, ENCDC that do 
colonize the bowel in Impdh2 conditional mutant mice are delayed and demonstrate 
incomplete Cre/loxP recombination, indicating a strong selective pressure against Impdh2 
deletion. Collectively these data support the need for de-novo guanine nucleotide synthesis 
and cell proliferation during neural crest development and are consistent with the hypothesis 
that IMPDH1 does not adequately supply metabolic guanine nucleotide needs for these 
neural crest-derived cell populations.
Materials and Methods
Impdh2 Gene Targeting
The pOSfrt-loxP vector (Provided by Randy Thresher, Lineberger Comprehensive Cancer 
Center Animal Models Core) containing a FRT-flanked positive selection marker (MC1-
Neo) and a negative selection marker (PGK-TK) was used to assemble the Impdh2 targeting 
construct from a 129/SV derived mouse genomic Impdh2 clone (Agilent Lambda FIX II). A 
XbaI/XbaI fragment containing Impdh2 exons 10–14 and 3′ flanking region (4.6 kb ‘long 
arm’) was filled-in using T4 DNA polymerase (Promega) and cloned into the PmeI site of 
pOSfrt-loxP using T4 DNA ligase (NEB) 3′ to the FRT-flanked MC1-Neo cassette. A 
second 3.5 kb fragment was synthesized by PCR using one primer located in intron 1 (5′ 
AAG GGT ACC CAT ATG TGA AGC AGG GGC AGG GGT TTA GAG G 3′) and a 
second loxP sequence-containing primer located in intron 9 (5′ CCG GGT ACC ATA ACT 
TCG TAT AAT GTA TGC TAT ACG AAG TTA TAG AGA TGC CAA GTC AGG CCT 
TGC C 3′). KpnI restriction sites at both ends of the amplified product were utilized to clone 
the fragment into the KpnI site of pOSfrt-loxP between the FRT-flanked MC1-Neo cassette 
and the 4.6 kb “long arm”. The entire PCR insert was sequenced and confirmed to be void of 
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mutations. To complete the targeting construct, a 3.3 kb XbaI/NdeI fragment containing the 
5′ end of Impdh2 (5′ flanking sequence through exon 1, ‘short arm’) was filled-in and 
ligated into the PmlI site of pOSfrt-loxP containing the other two fragments, between the 
PGK-TK gene and the FRT-flanked MC1-Neo cassette. Sequencing of the completed 
targeting vector (Figure S1) revealed that the most 5′ portion of this fragment was phage 
vector DNA located between Impdh2 genomic sequences and the PGK-TK cassette, and that 
the homologous ‘short arm’ was 1.3 kb long.
Transfection and selection of E14TG2a (129/Ola) ES cells and generation of chimeras was 
performed by the Animal Models Core of the UNC-Lineberger Comprehensive Cancer 
Center. A total of 96 electroporated ES cell clones (A1-H12) were screened by PCR using 
the forward primer 5′-AACATGTCAGGAACCCTGCC-3′, located upstream and outside of 
the region of homologous recombination, and the reverse primer 5′-
ACGCGTCACCTTAATATGC-3′ located in the Neo cassette using Takara LA Taq DNA 
Polymerase (Clontech Laboratories). Three PCR positive clones B3, C4 and D7 yielded a 
correctly sized 2206 bp product. The positive status of these clones were confirmed by two 
independent Southern blot analyses utilizing ES cell genomic DNA digested with the 
restriction enzymes XbaI and SalI, respectively. A 792 bp DNA fragment obtained from 
129/Ola ES cell genomic DNA (spanning bp positions −772 through +20 relative to the 
translation start site and encompassing the Impdh2 promoter through Exon 1) served as the 
Southern probe and was labeled using random priming (Prime-a-Gene, Promega). Southern 
blot analysis employing XbaI resulted in the expected 3502 bp and 1654 bp DNA fragments 
representing the WT and targeted IMPDH 2 alleles, respectively (Figure 1C). Southern blot 
analysis employing SalI resulted in 17312 bp and 12533 bp DNA fragments representing the 
WT and targeted IMPDH 2 alleles, respectively (not shown). A single correctly targeted ES 
cell clone, C4, was selected for microinjection, and the resulting agouti male chimeras were 
bred to C57Bl/6 females to accomplish germline transmission. The MC1-Neo cassette was 
excised by mating to Flp-recombinase expressing mice to produce the Impdh2tm2Bmi 
(referred to subsequently as Impdh2loxP) allele.
Animals and Genotyping
Animal experiments were approved by the Washington University Animal Studies 
Committee, The Institutional Animal Use and Care Committee at The Children’s Hospital of 
Philadelphia Research Institute, and the University of North Carolina – Chapel Hill’s 
Institutional Animal Care and Use Committee. All mice were maintained on mixed genetic 
backgrounds with functional HPRT-mediated purine salvage. Since E14TG2a ES cells carry 
the Hprtb-m3 null mutation, PCR was used to confirm that the Impdh2loxP strain did not carry 
Hprtb-m3 (Lake et al., 2013) prior to experimental matings. Cre-mediated recombination of 
the Impdh2loxP allele results in a frameshift after codon 32 and a premature stop after codon 
48, preventing expression of the catalytic domain. To produce a conventional knock-out 
allele, Impdh2loxP/+ mice were bred to Tg(ACTB-cre)2Mrt/J “Actin-Cre” mice (Lewandoski 
et al., 1997 RRID:IMSR_JAX:003376) resulting in pups carrying a germline deletion: 
Impdh2tm2.1Bmi (referred to as Impdh2Del). Actin-Cre was then removed through further 
breeding prior to experimental matings. Impdh2loxP mice were bred to 
Gt(ROSA)26Sortm1(EYFP)Cos (Srinivas et al., 2001 RRID:IMSR_JAX:006148) mice 
Lake et al. Page 4
Dev Biol. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(referred to as Rosa26EYFP) which permanently marks all Cre-expressing cells and their 
descendants with EYFP expression. Impdh2loxP and Impdh2Del mice were bred to Tg(Wnt1-
cre)11Rth (Danielian et al., 1998 RRID:IMSR_JAX:003829) mice, (referred to as Wnt1-
Cre), which drives loxP recombination in the entire neural crest and the dorsal tissues of the 
neural tube of the midbrain and hindbrain (Jiang et al., 2002). These strains were 
intercrossed as indicated using timed matings to produce Wnt1-Cre Impdh2loxP/+ conditional 
heterozygotes (control animals) and the two conditional knockout genotypes, Wnt1-Cre 
Impdh2loxP/loxP and Wnt1-Cre Impdh2loxP/Del, with and without the Rosa26EYFP reporter.
The vaginal plug day was counted as embryonic day 0.5. For collection of fetal samples, 
dams were euthanized with CO2 according to institutionally-approved procedures. 
Embryonic day 18.5 (E18.5) fetuses were euthanized by decapitation except for fetuses to be 
processed for bone and cartilage staining, which were anesthetized prior to immersion 
fixation. Tail DNA was prepared using the HotSHOT method (Truett et al., 2000) and 
genotyped using a previously described PCR genotyping protocol (Stratman et al., 2003). 
Genotyping reactions for Cre recombinase-containing transgenes and Rosa26EYFP used 
previously described primers (Lake et al., 2013; Stratman et al., 2003). The Impdh2+ and 
Impdh2loxP alleles were genotyped using primer pair Impdh2-F: 5′GAC TAC CTG ATT 
AGC GGA GGC ACC TCT TAC3′ and Impdh–5FRTlox-R: 5′CAC GCT AAC ATA TTC 
CAC ATA TCC AGA GAA3′, producing a 320 bp band from the wild-type allele and a 450 
bp band from the conditional allele. The Impdh2Del allele was genotyped with primer pair 
Impdh2-F and Impdh–3lox-R: 5′CTG AAA GAC ACC TAT ACC AAG TCC ATA GCC3′ 
resulting in a 650 bp band indicating the presence of the deleted allele. All analyzed mice 
were hemizygous for the Wnt1-Cre transgene and heterozygous for Rosa26EYFP if it was 
present.
Bone and Cartilage Staining
Simultaneous staining with alizarin red S and alcian blue was performed essentially as 
described in (McLeod, 1980). E18.5 mouse fetuses were fixed in 95% ethanol for two hours, 
after which skin and organs were removed and fixation was continued for one week. 
Samples were moved to acetone for two days and then stained for 3 days at 37 °C in 0.015% 
alcian blue (Sigma #A5268), 0.005% alizarin red S (Sigma #5533), 5% glacial acetic acid, 
and 70% ethanol. Samples were washed with water and rocked in a 1% KOH solution at 
room temperature until skeletons became visible after 48 hours. Samples were then passed 
through a graded series of 20–80% glycerol/1% KOH baths over the course of several weeks 
until tissues cleared. Skeletal preparations were stored and photographed in 100% glycerol.
Whole-mount Immunofluorescent Staining
Enteric neurons were labeled in E18.5 fetal mouse bowel using human ANNA–1 antiserum 
(A gift of Vanda Lennon, Mayo Clinic, RRID:AB_2313944), which stains the somas of all 
enteric neurons (Lennon, 1994) with the same pattern as the anti HuC/HuD monoclonal 
antibody used in previous studies (Lake et al., 2013). Fetal bowel was harvested, flushed 
with PBS, fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 
minutes at room temperature, and then incubated in blocking solution for 1 hour at 37 °C: 
5% normal goat serum (Jackson ImmunoResearch #005–000–121), 1% cold water fish-skin 
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gelatin (Sigma #G7765), 100 mM Glycine in Tris-buffered saline pH 7.5 with 1% Triton-X 
100 (TBST). Samples were then incubated overnight at 4 °C in ANNA–1 antiserum diluted 
1:2000 in ANNA–1 diluent (5% normal goat serum, 1% bovine serum albumin, and 0.2% 
sodium azide in PBS). Samples were washed 3 times with PBS and incubated with Alexa–
594 conjugated goat anti-human secondary antibody (1:400, Life Technologies #A–11014, 
RRID:AB_10375428) at 37 °C for 1 hour in PBS. After 3 washes with PBS, samples with 
the Rosa26EYFP reporter were incubated overnight at 4 °C with chicken anti-GFP (1:1000, 
Aves Labs #GFP–1020, RRID:AB_10000240) in blocking solution, washed 3 times with 
TBST, incubated for 1 hour at 37 °C with Alexa–488 conjugated goat-anti-chicken (1:400, 
Life Technologies #A–11039, RRID:AB_10563770), and washed 3 times with PBS.
Embryonic day 13.5 (E13.5) fetuses were pulse-labeled by maternal intraperitoneal 
bromodeoxyuridine (BrdU) injections (100 μg/gram body weight) with a one-hour chase. To 
label ENCDCs in EYFP-negative and some EYFP positive samples, a polyclonal rabbit 
antibody was used that was originally raised against SOX9 (Smith et al., 2005, rabbit anti-
SoxE, RRID:AB_2491620) and reacts with the other Sox group E proteins, SOX8 and 
SOX10. SOX9 is not expressed in the neural crest at this time point and SOX8 and SOX10 
are co-expressed in ENCDCs (Maka et al., 2005). Fetal bowel was harvested, processed, and 
stained for EYFP, cleaved-caspase 3 (Cell Signaling #9661, RRID:AB_2341188) or for 
SOXE exactly as described (Lake et al., 2013), except that rat anti-BrdU (1:400, BU1/75, 
Abcam #ab6326, RRID:AB_305426) and Alexa–594 conjugated donkey anti-rat (1:400, 
Life Technologies A–21209, RRID:AB_10562899) was used to visualize BrdU 
incorporation instead of a fluorophore-conjugated primary antibody. All samples were 
mounted on slides and visualized in 50% glycerol/PBS.
TUNEL Assay and Immunofluorescent Staining of Cryosections
Apoptosis was detected in 12 μm cryosections of E9.5 whole embryos using the In Situ Cell 
Detection Fluorescein Kit (Roche 11684795910) according to the manufacturer’s 
instructions. Briefly, cryosections of fixed embryos were first treated with PBS containing 
0.1% Triton X-100 for 2 minutes. Following three PBS rinses, cryosections were incubated 
in a TUNEL-Mix containing 90 μL TUNEL label and 10 μL TUNEL enzyme in the dark for 
1 hour at 37 °C. Adult liver cryosections were included in each experiment as a positive 
control for TUNEL labeling. To perform immunofluorescence staining, cryosections were 
then blocked for 1 hour in 5% normal donkey serum (Jackson ImmunoResearch 
017-000-121), incubated overnight at 4 °C in rabbit-anti-SOX E (1:300), washed three times 
with PBS, incubated for one hour with Alexa–594 conjugated donkey-anti-rabbit (1:400, 
Life Technologies A-21207), and washed three times with PBS before visualization in 
VECTASHIELD mounting medium with DAPI (Vector Laboratories H-1200).
Microscopy and Measurement
Photographs of whole fetuses, skeletal preparations, and hearts were acquired on an 
Olympus SZ–40 stereomicroscope. EYFP fluorescent micrographs of whole fetuses were 
acquired on a Nikon SMZ1500 stereomicroscope using a GFP-B epifluorescence filter. 
Measurements of colonization, aganglionosis and hypoganglionosis were conducted on an 
IX71 epifluorescence microscope guided by ANNA–1 staining at E18.5 or by SOXE and 
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EYFP staining at E13.5. Images of fluorescent whole-mount bowel were acquired as wide-
field fluorescent micrographs on a Zeiss Axio Observer.Z1 or as multiple optical sections 
using either a Zeiss Apotome.2 structured illumination device or an Olympus FV1000 point-
scanning confocal microscope. BrdU positivity within EYFP-positive cells was manually 
counted from confocal volumes. All optically sectioned samples are presented as maximum 
intensity projections through 20 micron-thick volumes unless otherwise indicated. Image 
processing was performed in ImageJ software (Schneider et al., 2012 RRID:nif-0000-30467) 
and was limited to stitching of multiple fields (Preibisch et al., 2009), rotation, cropping, 
uniform brightness and contrast adjustments, and maximum intensity projection of volumes, 
with the exception of EYFP fluorescent micrographs of whole E13.5 fetuses, which were 
subjected to local contrast enhancement using contrast limited adaptive histogram 
equalization (CLAHE) (Schindelin et al., 2012) to improve the contrast of EYFP-containing 
tissue.
Statistical Analysis
Statistical tests were performed using the R software package (R. Core Team, 2012 
RRID:nif-0000-10474). Student’s t test was used to compare E13.5 bowel colonization and 
rates of BrdU incorporation within ENCDCs. Multiple comparison adjustments were 
performed with the Holm-Boniferroni method based on the number of planned comparisons.
Results
Impdh2 deletion in the neural crest results in craniofacial and cardiac defects
Guanine nucleotides can be produced either de novo via IMPDH1/IMPDH2 or by the purine 
salvage pathway. To determine whether Impdh2 is required within the neural crest lineage 
for ENS development or whether Impdh1 and/or purine salvage from adjacent tissue could 
provide adequate GMP once embryonic lethality was bypassed, we used the Wnt1-Cre 
transgene to delete a conditional Impdh2loxP allele (Figure 1) in the early neural crest. As 
expected, both Impdh2loxP/loxP and Impdh2loxP/Del mice lacking Wnt1-Cre survived to 
adulthood and were fertile. While Wnt1-Cre Impdh2loxP/+ mice appeared normal, Wnt1-Cre 
Impdh2loxP/loxP mice did not survive after birth, though they did develop to term. At E18.5, 
Wnt1-Cre Impdh2loxP/loxP fetuses had profound malformations of the anterior head (Figure 
2A,E) including a near-total absence of the jaw and a protruding brain that was not covered 
by bone. Eyes were sometimes open, and ear pinnae were rudimentary. Bone and cartilage 
staining revealed that most skeletal structures anterior to the parietal (dorsal) or basisphenoid 
(ventral) bones were reduced or ablated, and the remaining structures consisted of irregular 
spicules of bone and cartilage (Figure 2B–D,F–H). Notably, these structures are normally 
neural crest-derived. Several posterior elements of the skull that are neural crest-derived are 
also reduced or missing in Wnt1-Cre Impdh2loxP/loxP fetuses, such as the interparietal bone 
and tympanic rings (Huang et al., 2010; Jiang et al., 2002). Because neural crest also 
contributes to portions of several neck and shoulder bones (Matsuoka et al. 2005), we further 
inspected the clavicle, sternum, scapular spine, and spinous process of the cervical vertebrae 
in Wnt1-Cre Impdh2loxP/loxP fetuses, but found no gross abnormalities in these structures 
(Figure 2I–N). Since our previous experiments with IMPDH inhibition also revealed heart 
defects in exposed fetuses, we examined hearts at E18.5 using dye injection into the left 
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ventricle and observed outflow tract and great vessel defects in 4 of 8 Wnt1-Cre 
Impdh2loxP/loxP fetuses (Figure 2O–Q).
Neural crest-specific deletion of Impdh2 results in bowel aganglionosis
Examination of enteric neurons in E18.5 fetal bowel using ANNA–1 (anti-HuC/HuD) 
staining revealed normal colonization in Wnt1-Cre Impdh2loxP/+ fetuses while deletion of 
Impdh2 in the neural crest of Wnt1-Cre Impdh2loxP/loxP fetuses resulted in severe defects of 
the ENS including highly-penetrant aganglionosis of variable length (Figure 3A–C) ranging 
from very short colonic aganglionosis to total intestinal aganglionosis. In bowels that 
contained normally-innervated regions, those regions were always oral to hypoganglionic 
and aganglionic regions, strongly suggesting that Impdh2 deletion causes a vagal ENCDC 
colonization defect. Some isolated enteric neurons were also found in the walls of otherwise 
aganglionic colons and are possibly of sacral neural crest origin. We were concerned that the 
variable phenotype seen in the conditional knockout was due to the presence of two “floxed” 
alleles of Impdh, resulting in either incomplete recombination or a failure to reduce 
IMPDH2 protein levels quickly enough to produce a complete phenotype in the ENS. To 
address this concern, we converted one copy of Impdh2loxP to the deleted allele Impdh2Del 
in the germline and examined the phenotype of Wnt1-Cre Impdh2loxP/Del fetuses. This 
configuration requires only a single recombination event to delete Impdh2. This strategy 
greatly increased the severity of the ENS phenotype. (Figure 3A,D).
Impdh2 deleted ENCDCs colonize the bowel abnormally
Because of the distal aganglionosis apparent at E18.5, we examined the effects of Impdh2 
deletion as the ENCDC migration process nears completion at E13.5 using a mouse strain 
that expresses EYFP after Cre-induced DNA recombination, Rosa26EYFP. The craniofacial 
defects that result from Impdh2 deletion were readily apparent at E13.5. While lineage-
marked EYFP+ cranial neural crest cells did migrate to the expected regions of the anterior 
head in Wnt1-Cre Impdh2loxP/loxP and Wnt1-Cre Rosa26EYFP Impdh2loxP/Del fetuses, the 
resulting structures were abnormal in Wnt1-Cre Rosa26EYFP Impdh2loxP/loxP embryos and 
the pharyngeal arches were almost entirely absent in the Impdh2loxP/Del genotype (Figure 
4A,C,E). In the ENS, Wnt1-Cre Impdh2loxP/+ colons were uniformly colonized at E13.5 as 
indicated by EYFP fluorescence or SOXE staining. In contrast, both Wnt1-Cre 
Impdh2loxP/loxP and Wnt1-Cre Impdh2loxP/Del genotypes showed severe colonization defects 
at E13.5 (Figure 4B,D,F–G) and colonization in the Wnt1-Cre Impdh2loxP/Del genotype was 
slightly but significantly reduced relative to Wnt1-Cre Impdh2loxP/loxP (Figure 4G). The 
structure of the proximal colonized regions of the ENS was also abnormal in both 
conditional knockout genotypes. In Impdh2loxP/+ fetuses, the ENCDCs immediately behind 
the wavefront were organized into chains of cells (Figure 4B), quickly transitioning into a 
high-density network more proximally. In contrast, Wnt1-Cre Impdh2loxP/loxP and Wnt1-Cre 
Impdh2loxP/Del bowel contained long stretches of low-density ENCDC strands and even 
isolated ENCDCs (Figure 4D,F). Notably, the proximal colonized areas of E18.5 bowel 
appeared essentially normal (Figure 3), indicating that these sparse strands of ENCDCs did 
expand between E13.5 and E18.5 to populate the colonized regions of the proximal bowel. 
In an effort to determine the fate of Impdh2-deficient ENCDCs, we measured DNA 
synthesis and apoptosis at E13.5 using BrdU labeling and cleaved-caspase 3 staining. We did 
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not detect significant numbers of cleaved-caspase 3 reactive ENCDCs of any genotype and 
found that BrdU incorporation in the EYFP-positive cells of E13.5 Impdh2loxP/Del bowel 
was not significantly reduced relative to EYFP-positive cells at the migration wavefront in 
Impdh2loxP/+ fetuses (Figure 5). Additionally, analysis of cell death using TUNEL assay at 
E9.5, an age when vagal neural crest progenitors begin invading the proximal bowel, also 
revealed no significant apoptosis in mice of any genotype (Figure 6).
Wnt1-Cre incompletely recombines the Rosa26EYFP reporter in the ENS of Impdh2 
conditional knockouts
E18.5 fetuses that also carried the Rosa26EYFP reporter displayed an unexpected phenotype. 
In Wnt1-Cre Impdh2loxP/+ bowel (N=4 EYFP-positive samples) stained for both ANNA-1 
and EYFP, all neurons were EYFP-positive (Figure 7A), as expected given the Wnt1-Cre 
fate map (Jiang et al., 2002). However, in every Impdh2loxP/loxP Rosa26EYFP fetus (N=3 
EYFP-positive samples), mixtures of varying numbers of EYFP-positive and EYFP-negative 
neurons were clearly visible (Figure 7B–C). The degree of incomplete recombination varied 
both between animals and between regions of a single bowel, reflecting the clonal mixing 
that occurs during ENS development (Binder et al., 2012; Rothman et al., 1993; Young and 
Newgreen, 2001). Similarly, when we examined Wnt1-Cre Impdh2loxP/+ and Wnt1-Cre 
Impdh2loxP/Del bowels carrying the Rosa26EYFP reporter at E13.5 and stained for SOXE and 
EYFP, we observed many EYFP-negative ENCDCs in the Impdh2loxP/Del fetuses (2 of 4 
embryos, Figure 7D–E). After searching the colonized regions of Wnt1-Cre Impdh2loxP/+ 
bowels marked by EYFP (N=6), we found only a few scattered EYFP-negative SOXE-
positive ENCDCs in a single embryo (Figure 7E), indicating that while Wnt1-Cre mediated 
recombination in the ENS is highly efficient, it is not universal, and that the degree of 
incomplete labeling for EYFP is influenced by the Impdh2 genotype.
Discussion
A neural-crest autonomous requirement for Impdh2
Deletion of Impdh2 in the early neural crest results in craniofacial defects including near-
total ablation of skull structures derived from the neural crest (Chai et al., 2000; Jiang et al., 
2002). This includes the skeleton anterior to the basisphenoid and parietal bones as well as 
the tympanic rings and the interparietal bone in the posterior skull (Figure 2). Bones in the 
neck and shoulder region known to receive neural crest contributions (Matsuoka et al. 2005) 
appeared grossly normal. Since these bones are only partially composed of neural crest 
derived cells, it is possible that subtle defects are present that could not be detected with the 
bone and cartilage staining performed. Alternatively, mesodermal progenitors may be able to 
compensate for the lack of neural crest derived cells in these structures.
Conditional Impdh2 knockout fetuses also demonstrated cardiac outflow tract and great 
vessel defects. These phenotypes bear a striking resemblance to the pan-neural crest defects 
that result from experimental ablation of the Wnt1-Cre fate map using Cre recombinase-
triggered expression of diphtheria toxin fragment-A (Olaopa et al., 2011) or HSV-Tk 
followed by ganciclovir treatment (Porras and Brown, 2008), which suggests that neural 
crest derivatives lacking Impdh2 fail to expand, survive, or differentiate properly. Taken 
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together with the catastrophic results of Impdh2 deletion in the ENS, these results reinforce 
our previous findings that global IMPDH inhibition results in cardiac and ENS defects (Lake 
et al., 2013). However, our previous work could not separate the effects of IMPDH 
inhibition on ENCDCs and non-neural crest tissues such as the bowel mesenchyme, which 
manifested as global growth restriction and reduced intestinal length in exposed fetuses. The 
current experiments clearly show that Impdh2 is required in ENCDCs and other neural crest 
derivatives, and that the resulting ENS defects occur in the context of an entirely normal 
bowel microenvironment. Moreover, guanine salvage from this normal neighboring tissue 
and any residual GMP synthesis by IMPDH1 cannot compensate for the loss of IMPDH2.
Incomplete recombination in conditional deletion of Impdh2
The aganglionosis observed in Impdh2 conditional knockout bowel demonstrates the 
necessity of IMPDH2 for ENS development, while the incomplete recombination seen in the 
ENS (Figure 7) of these fetuses provides indirect evidence that loss of Impdh2 dramatically 
reduces the ability of neural crest-derived cells to populate fetal bowel. The Wnt1-Cre 
transgene has been used extensively to delete genes in and mark the cells of the ENS (Zehir 
et al., 2010; Fuchs et al., 2009; Okamura and Saga, 2008; Van de Putte et al., 2007), and we 
are unaware of any previous instances where incomplete recombination has been 
demonstrated in Wnt1-Cre mice, although it has been suggested that it may account for 
some otherwise contradictory results (D’Autréaux et al., 2007; Hendershot et al., 2007). 
Indeed, we observed only rare instances of incomplete recombination of the EYFP reporter 
in E13.5 Impdh2loxP/+ Rosa26EYFP fetuses (Figure 7), suggesting that Cre-induced 
recombination is nearly complete in the ENS of Wnt1-Cre mice. The Impdh2loxP/loxP 
conditional knockout, on the other hand, shows clear evidence of incomplete recombination 
of the Rosa26 reporter. Since each Cre-catalyzed recombination event is independent, when 
reporter recombination is incomplete we can no longer assert with confidence that every 
EYFP-positive cell has recombined the gene of interest. Because the Wnt1-Cre transgene is 
very efficient in conditional heterozygotes, we suspected that Impdh2loxP/loxP cells escaping 
recombination had a strong selective advantage early in neural crest development, leading to 
their overrepresentation in the ENS of conditional knockout fetuses. We also suspected that 
incomplete deletion of Impdh2 could account for the variability in ENS phenotype. Since the 
Impdh2 allele used in this study lacks an internal recombination reporter and all available 
anti-IMPDH antibodies suitable for immunohistochemistry lack specificity for IMPDH2, we 
attempted to circumvent this problem by using the Impdh2loxP/Del Rosa26EYFP genotype, 
reasoning that reducing the number of required recombination events from 3 to 2 might 
make both deletion and lineage marking more uniform. However, examination of the 
ENCDC population indicates that this was not entirely successful, since many SOXE-
positive cells in Impdh2loxP/Del Rosa26EYFP bowels still escaped recombination at the 
Rosa26 locus.
Using the Impdh2loxP/Del genotype likely increased Impdh2 deletion efficiency and reduced 
the number of proliferation-competent cells entering the bowel, since the migration 
phenotype in Impdh2loxP/Del embryos at E13.5 was significantly worse than in mice with the 
ImpdhLoxP/LoxP genotype and ENCDC migration depends largely on population size and 
proliferation (Barlow et al., 2008; Simpson et al., 2007). The relatively normal BrdU 
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labeling index in Wnt1-Cre Impdh2loxP/Del ENCDCs is also easily accounted for if the 
ENCDCs that do colonize the bowel in Impdh conditional mutant mice have preferentially 
not undergone recombination at the Impdh2 locus despite sporadically recombining the 
Rosa26EYFP reporter.
Incomplete lineage labeling is an inherent hazard of experiments that use separate target and 
reporter alleles. However, independent recombination of multiple loci does not necessarily 
explain why the Impdh2loxP/Del Rosa26EYFP genotype produced obviously incomplete 
lineage labeling while the Impdh2loxP/+ Rosa26EYFP genotype, containing the same number 
of loxP-flanked recombination targets (two), produced an almost perfectly labeled ENS.
An alternative explanation for the unlabeled neural-crest derivatives is that the unlabeled 
cells might comprise a separate sublineage of ENCDCs that does not express the Wnt1-Cre 
transgene, and expands in reaction to depletion of surrounding ENCDCs. This possibility is 
important to consider because the existence of such a subpopulation could imply a currently 
unappreciated early specification or lineage restriction within the enteric neural crest and 
because heterogeneity in Wnt1-Cre expression has far-reaching consequences for 
interpreting the many experiments performed using this system. However, the near-total (far 
fewer than 1 in 1000 cells escape in control fetuses) labeling of all fetal and term ENS cells 
in Impdh2loxP/+ animals is inconsistent with a distinct lineage, unless it normally contributes 
vanishingly few cells to the ENS. In contrast, a more numerous distinct ENS lineage has 
been described that normally comprises about 15% of ENCDCs and is defined by non-
expression of a Nestin-Cre transgene. (Lei and Howard, 2011). This lineage increases its 
proliferation in reaction to the deletion of Hand2 (a transcription factor required for multiple 
aspects of ENS development) within the remaining 85% of ENCDCs (which express Nestin-
Cre) and is also distinguished as a unique linage by preferentially generating neurons rather 
than glia, in contrast to other ENCDCs. Similarly, when Foxd3 (a transcription factor 
required for neural-crest cell self-renewal) is deleted by a Ednrb-iCre (codon optimized Cre) 
transgene, ENCDCs that do not express the Ednrb-iCre transgene (normally comprising 
about 5% of p75+ cells) preferentially expand to compensate for absent recombined cells 
(Mundell et al., 2012). In the latter case, it is not clear whether this population represents a 
lineage with distinct properties or is the effect of variegated transgene expression.
Finally, differences in efficiency of Cre/loxP-mediated recombination between the Impdh2 
and Rosa26 loci should be considered as a possible source of unlabeled neural crest 
derivatives. Efficiency of intramolecular Cre-mediated recombination is known to be 
reduced with increasing length between loxP sites (Wang et al., 2009; Zheng et al., 2000), 
but the sizes of the flanked region in Impdh2 (3.5 kb) and Rosa26EYFP (2.8 kb) do not 
differ enough to skew recombination significantly. It is also known that different genomic 
loci have different efficiencies of recombination due to chromatin state, base composition, or 
other factors (Hara-Kaonga et al., 2006; Vooijs et al., 2001). Again, it is difficult to explain 
with this framework why unlabeled enteric neurons and ENCDCs would be more numerous 
in the Impdh2loxP/loxP and Impdh2loxP/Del genotypes.
Because expansion of the rare ENCDCs that escape recombination most parsimoniously 
explains the increased number of EYFP negative ENCDCs in the Impdh2loxP/loxP and 
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Impdh2loxP/Del genotypes and accounts for the lack of a proliferation defect in EYFP-labeled 
cells, we favor this interpretation.
Fate of ENCDCs in Impdh2 conditional mutant fetuses
Consistent with results from mice treated with the IMPDH inhibitor MPA (Lake et al., 
2013), we saw no increase in apoptosis of ENCDCs in Impdh2 conditional mutants, either at 
E9.5 (Figure 6) or E13.5. This suggests that Impdh2 depletion does not result in increased 
progenitor or ENCDC cell death, at least not through canonical apoptosis. It is however 
possible that at E9.5, progenitors are not yet fully IMPDH2 or guanine nucleotide depleted, 
and that increased apoptosis occurs in the time window between the two sampled time points 
(i.e. between E9.5 and E13.5).
Our data also suggest that there is ongoing ENCDC proliferation in conditional Impdh2 
mutant bowel between E13.5 and E18.5 since the bowel is more densely colonized by 
ENCDC at the later time point (Figures 3 and 4). This observation supports the idea that the 
sparsely colonized ENS network in fetal bowel is made up of “fugitive” ENCDCs whose 
ancestors escaped recombination and that these cells adaptively expand to fill the 
underpopulated bowel (Natarajan et al., 1999). To our knowledge, it is not known how long 
CRE activity from the Wnt1-Cre transgene lasts in the migratory neural crest. Expression of 
a similar Tg(Wnt1-LacZ) transgene in the developing ENS was lost after E11.5 (Kapur, 
2000), suggesting that the rare ENCDC that had not yet recombined at that time would 
permanently escape Cre-mediated DNA recombination. It is also possible that non-
recombined cells support some degree of migration of Impdh2-deleted cells through the 
bowel, since ENCDCs clones mix extensively and non-cell autonomous rescue of ENCDC 
migration occurs in aggregation chimeras (Kapur et al., 1996, 1995) and in tissue culture 
(Lake et al., 2013). In the absence of a method to directly detect Impdh2 recombination on a 
cell-by-cell basis, we cannot determine if all ENCDC that colonize the bowel in mutant mice 
retain IMPDH2 expression.
In the absence of detectable proliferation defects or the induction of cell death, it is not 
obvious why impaired colonization of the bowel by ENCDC occurs. However, our data 
suggest that Impdh2 deletion dramatically reduces the ability of ENCDCs to colonize fetal 
bowel. The small number of ENCDCs that remain replication and migration competent 
because they fail to recombine the Impdh2 locus (< 1:1000 in Wnt1-Cre reporter lines), 
would need to divide and migrate very rapidly to produce a normal ENS before the bowel 
microenvironment becomes nonpermissive to further colonization (Hotta et al., 2010). As 
other studies have shown, reducing the number of ENCDCs that enter the bowel (Barlow et 
al., 2008) is sufficient to cause aganglionosis and artificially reducing the density of 
ENCDCs impairs their migration (Young et al., 2004) even if the remaining ENCDCs are 
healthy. This can account for the failure of the remaining ENCDCs to colonize the distal 
portions of the bowel. One notable exception to this is in Tcof1+/− haploinsufficient fetuses, 
where even very severe reductions in the number of ENCDCs entering the bowel are 
completely compensated for by a combination of increased ENCDC proliferation, decreased 
enteric neuron differentiation, and impaired microenvironment maturation (Barlow et al., 
2012). In the case of Impdh2 neural-crest specific deletion, aganglionosis results despite 
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apparent compensatory ENCDC proliferation from incompletely recombined cells, probably 
because bowel mesenchyme becomes inhospitable for further ENCDC proliferation and 
migration as development proceeds..
Unexpectedly, there appears to be less bowel colonization at E18.5 than at E13.5 in 
Impdh2loxP/Del mice (Figures 3, 4). Since we did not detect increased ENCDC apoptosis in 
mutant embryos at E13.5, this apparent regression might be explained by the dramatic 
lengthening of the midgut (post-ampullary small bowel) relative to the foregut (pre-
ampullary small bowel) between E13.5 and E18.5. It is also possible that either apoptotic or 
non-apoptotic, non-necrotic cell death (Uesaka and Enomoto, 2010) occurs in ENCDCs at 
any time between E13.5 and E18.5 and was not detected due to event rarity or the time 
chosen for sampling. Alternatively, the nascent ENCDCs in the most distal region of 
colonized bowel could preferentially differentiate into glia. This would be difficult to detect, 
since extrinsic nerve fibers present in aganglionic regions carry their own Schwann cells 
which are indistinguishable from intrinsic enteric glia by immunohistochemical markers.
Conclusions
Taken together with our prior study demonstrating that chemical inhibition of IMPDH 
results in aganglionosis by reducing ENCDC proliferation (Lake et al., 2013), these 
experiments identify IMPDH2 as uniquely required for the development of the ENS. This is 
especially interesting since human genetic studies have independently identified a risk locus 
at 3p21 in Hirschsprung disease (Gabriel et al., 2002), and the IMPDH2 gene is located at 
3p21. In that analysis, the 3p21 risk allele appeared to enhance the effect of RET mutations, 
the primary causative mutation in most cases of Hirschsprung disease (Amiel et al., 2008). A 
subsequent study has mapped this risk locus to an interval 0.6 megabases from IMPDH2 
(Garcia-Barceló et al., 2008). Other modifier mutations are well-appreciated contributors to 
Hirschsprung disease (Carrasquillo et al., 2002; de Pontual et al., 2007; Garcia-Barcelo et 
al., 2009), and future studies will investigate whether known (Wang et al., 2007) or novel 
genetic variation in human IMPDH2 is associated with Hirschsprung disease.
Because IMPDH inhibition impairs ENS development and the Impdh2 gene is indispensable 
for embryonic survival, we examined whether Impdh2 is required in the neural crest lineage 
for its proper development. Wnt1-Cre-mediated deletion of Impdh2 resulted in severe 
craniofacial and heart defects, as well as extensive aganglionosis of the ENS. During initial 
ENS development, ENCDC colonization in conditional knockout fetuses was impaired and 
the remaining colonized regions were abnormally hypocellular. Furthermore, both the 
developing and definitive ENS showed evidence of incomplete recombination that was 
specific to the conditional knockout genotype, demonstrating that Impdh2 deletion is 
strongly selected against in the neural crest-derived cells that eventually become the ENS. 
These results confirm a critical role for de novo guanine nucleotide synthesis and IMPDH2 
in the neural crest lineage, and indicate that IMPDH1 and the salvage pathway cannot 
compensate for IMPDH2 loss even when other tissues in the developing embryo are normal.
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Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Impdh2 is required for enteric nervous system, heart, and facial bone 
development.
• Impdh1 cannot substitute for Impdh2.
• Cell autonomous de novo guanine nucleotide synthesis is essential for neural 
crest.
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Figure 1. Production and structure of the Impdh2loxP and Impdh2Del alleles
(A) The Impdh2 targeting construct, shown above the corresponding wild-type Impdh2 
locus, contains loxP sequences (red triangles) in intron 1 and intron 9 while FRT sequences 
(hollow triangles) flank a MC1-Neo cassette immediately preceding the first loxP site. Flp-
mediated recombination excises the MC1-Neo cassette (B) from the targeted allele to 
produce the conditional Impdh2loxP allele. Cre-mediated recombination produces the 
Impdh2Del allele, which results in a frameshift (asterisk) and premature termination codon in 
the exon 3′ to the recombination site. After CRE-mediated DNA recombination, the IMPDH 
catalytic domain will be not be produced. (A and B): Intergenic restriction sites and those 
not resolved by Southern blot are omitted for clarity. (C) Southern blot of DNA from three 
PCR-positive ES cell clones digested with XbaI showing expected bands at 3502 bp (WT) 
and 1654 bp (targeted).
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Figure 2. Impdh2 deletion by Wnt1-Cre results in craniofacial and cardiac defects at term
At embryonic day 18.5 (E18.5), (A, E) Wnt1-Cre Impdh2loxP/loxP fetuses lack a jaw, 
external ear, or any mineralized bone in the anterior head. (B, F) superior, (C, G) inferior, 
and (D, H) lateral views of bone and cartilage stained skulls show that Wnt1-Cre 
Impdh2loxP/loxP fetuses have missing or severely reduced neural-crest derived skeletal 
structures of the head, including most structures anterior to the parietal and basiosphenoid 
bones as well as the neural crest derived interparietal bone and tympanic rings. In contrast, 
the sternum, clavicle (I,L), scapular spine (J,M), and spinous processes of the cervical 
vertebrae (K,N) appear grossly normal. bo = basiooccipital bone, bs = basisphenoid bone, eo 
= exooccipital bone, f = frontal bone, m = mandible, n = nasal bone, p = parietal bone, px = 
premaxilla, ip = interparietal bone, so = supraoccipital bone, tr = tymanic ring, x = maxilla, c 
= clavicle, s = sternum, sc = scapular spine, cv = cervical vertebrae, * = remnant or 
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abnormal structure. Scale bars in panels A–H = 5 mm. Scale bars in panel I-N = 2.5 mm. 
Injection of ink into the ventricles of control Wnt1-Cre Impdh2loxP/+ hearts (O) reveals 
normal anatomy of the great arteries. Wnt1-Cre Impdh2loxP/loxP hearts (P, Q) show 
representative malformations of the great vessels and outflow tract: P shows an interrupted 
aortic arch, where the left subclavian (ls) arises from the pulmonary artery instead of the 
aorta. In Q, the pulmonary artery fails to label with ink despite ink injection into the right 
ventricle, indicating pulmonic stenosis or atresia. a = aorta, p = pulmonary artery, b = 
brachiocephalic trunk, lc = left common carotid artery, ls = left subclavian artery, p* = 
atretic pulmonary artery. Scale bar = 2 mm.
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Figure 3. Impdh2 deletion by Wnt1-Cre causes highly penetrant aganglionosis of variable length 
at term
(A) At E18.5, all Wnt1-Cre Impdh2loxP/+ bowels are fully colonized by neurons, while 
Wnt1-Cre Impdh2loxP/loxP and Wnt1-Cre Impdh2loxP/Del intestines demonstrate distal 
aganglionosis reminiscent of Hirschsprung disease. Proximal to aganglionic bowel there is a 
hypoganglionic transition zone and eventually, in many cases, regions of relatively normal 
appearing proximal bowel. Each dot and line represents a separate fetus. Dots = position of 
the most caudal enteric neuron in each intestine, grey lines = hypoganglionic regions, 
vertical lines = mean positions of the most caudal ENCDC. (B) ANNA–1 (anti-HuC/HuD) 
staining of enteric neuron somata reveals that Wnt1-Cre Impdh2loxP/+ contain a dense 
network of enteric neurons throughout the bowel. (C–D) Conditional knockout genotypes 
contain variable regions of distal aganglionic bowel. (C) Shows aganglionic distal colon, 
hypoganglionic proximal colon and relatively normal regions of the ENS in the proximal 
small intestine. (D) Shows aganglionic colon and distal small bowel with a relatively normal 
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appearing enteric neuron density in proximal small bowel. ANNA–1 photomicrographs are 
maximum intensity projections of 20 micron-thick volumes. Scale bar = 100 μm.
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Figure 4. Impdh2 conditional knockout fetuses have cranial neural crest and ENCDC 
abnormalities at E13.5
(A, C, E) EYFP-positive neural crest derivatives have migrated to the anterior head in all 
genotypes, but in (C) Wnt1-Cre Rosa26EYFP Impdh2loxP/loxP fetuses, EYFP-positive tissue 
is reduced in size and has not fused at the ventral midline where the medial nasal 
prominence exists in Impdh2loxP/+ fetuses. In (E) Wnt1-Cre Rosa26EYFP Impdh2loxP/Del 
fetuses, EYFP-positive tissue is still present anterolaterally but does not form recognizable 
branchial arch structures. Scale bar = 1 mm. In (B) control bowel, SOXE-positive enteric 
neural crest-derived cells (ENCDCs) have colonized almost the entire bowel and have 
accumulated to a high density in colonized regions (small intestine and proximal colon). In 
(D) Wnt1-Cre Impdh2loxP/loxP and (F) Impdh2loxP/Del intestine, colonized regions are both 
significantly shorter and contain fewer cells, indicating a profound inability for ENCDCs to 
efficiently populate the intestine. Scale bar = 100 μm. Measurements (G) of colonization 
extent as well as colonized regions of bowel containing an unusually low ENCDC density 
reveal that Wnt1-Cre Impdh2loxP/Del intestine has a significantly worse colonization defect 
than Wnt1-Cre Impdh2loxP/loxP. Each dot and line represents a separate fetus. Dots = 
position of the most caudal ENCDC in each intestine as indicated by EYFP expression in 
Rosa26EYFP bowels or SOXE staining in Rosa26 WT bowels. Grey lines = regions of low 
ENCDC density. Vertical lines = mean positions of the most caudal ENCDC. * = P< .05, 
*** = P < .001 by Welch’s t-test on the most-caudal ENCDC positions.
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Figure 5. BrdU incorporation in ENCDCs of Impdh2 conditional knockout fetuses
(A) Immediately behind the migration wavefront in E13.5 Wnt1-Cre Rosa26EYFP 
Impdh2loxP/+ bowel, many EYFP-positive ENCDCs (green) incorporate bromodeoxyuridine 
(BrdU, red and merge). (B) At this time point, very few ENCDCs are present in the small 
intestine of Wnt1-Cre Rosa26EYFP Impdh2loxP/Del fetuses. Scale bar = 100 μm. Pictures are 
maximum intensity projections of 12 μm-thick volumes. (C) Quantification of BrdU 
incorporating nuclei within the EYFP-marked ENCDC population does not demonstrate a 
significant difference in BrdU incorporation between Impdh2loxP/+ (N = 5) and 
Impdh2loxP/Del (N = 4) genotypes. Note that different regions of the bowel are being 
compared, since each contains the migration wavefront in its respective genotype. ns = not 
significant by pooled-variance t-test. Error bars are s.e.m.
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Figure 6. TUNEL labeling of E9.5 vagal neural crest progenitors in Impdh2 conditional knockout 
embryos
Vagal neural crest progenitors labeled with SOXE are seen entering the foregut in both 
control and Impdh2 conditional knockout embryos, with no significant TUNEL labeling 
detected in mice of either genotype (A–F). Autofluorescent nucleated red blood cells are 
observed in all samples in the absence of primary antibody or TUNEL reagents (G–I). 
Apoptotic TUNEL-labeled cells are readily detected in positive control liver samples (J–L).
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Figure 7. Remaining enteric neurons and ENCDCs in Impdh2 conditional knockouts display 
incomplete recombination
In (A) morphologically normal colon of Wnt1-Cre Impdh2loxP/+ Rosa26EYFP control 
fetuses, all ANNA–1-positive (anti-HuC/HuD, red) enteric neurons are EYFP-positive 
(green) at E18.5, demonstrating that under normal circumstances Wnt1-Cre efficiently 
recombines the ancestors of essentially all ENCDCs. In (B) the hypoganglionic colon of one 
Wnt1-Cre Rosa26EYFP Impdh2loxP/loxP fetus and (C) the small bowel of another, more 
severely affected fetus with aganglionosis extending into the small bowel (C), many enteric 
neurons are not EYFP-positive, and the degree of incomplete labeling varies. (D–F) A 
similar phenomenon is already visible in the small intestine at E13.5. ENCDCs (SOXE-
positive, red) are uniformly EYFP-positive (green) in (D) most control Wnt1-Cre 
Rosa26EYFP Impdh2loxP/+ bowel. In (E), the individual SOXE-positive, EYFP-negative cells 
(identified by arrowheads) are the only examples of incomplete recombination found in the 
Wnt1-Cre Rosa26EYFP Impdh2loxP/+ genotype, likely representing a clone of ENCDCs 
derived from a rare neural crest cell that escaped recombination. In contrast, many SOXE-
positive ENCDCs are EYFP-negative (F) in Wnt1-Cre Rosa26EYFP Impdh2loxP/Del bowel. 
Dashed boxes = magnified insets. All scale bars = 100 μm. All photomicrographs are 
maximum intensity projections of 20 micron-thick volumes.
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